Miku Oda
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory and Cough-Related Research
- Pleural and Pulmonary Diseases
-
- Antifungal resistance and susceptibility
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Medical Imaging and Pathology Studies 4
- Pleural and Pulmonary Diseases 2
-
- IgG4-Related and Inflammatory Diseases 2
Miku Oda
16 papers receiving 149 citations
Peers
Comparison fields: 5 of 43
- Pulmonary and Respiratory Medicine 83
- Infectious Diseases 44
- Otorhinolaryngology 8
- Rheumatology 27
- Physiology 45
Countries citing papers authored by Miku Oda
This map shows the geographic impact of Miku Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miku Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miku Oda more than expected).
Fields of papers citing papers by Miku Oda
This network shows the impact of papers produced by Miku Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miku Oda. The network helps show where Miku Oda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miku Oda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 27 | |
| 4 | 2020 | 5 | |
| 5 | 2019 | 6 | |
| 6 | 2018 | 14 | |
| 7 | 2018 | 25 | |
| 8 | 2018 | 9 | |
| 9 | 2017 | 14 | |
| 10 | 2017 | 0 | |
| 11 | 2017 | 1 | |
| 12 | Clinical significance of the "galaxy sign" in patients with pulmonary sarcoidosis in a Japanese single-center cohort. | 2016 | 10 |
| 13 | 2016 | 1 | |
| 14 | 2013 | 18 | |
| 15 | 2013 | 4 | |
| 16 | 2012 | 5 | |
| 17 | 2008 | 2 | |
| 18 | Interleukin-1 beta and interleukin-1 receptor antagonist levels in cerebrospinal fluid of aseptic meningitis patients. | 1998 | 6 |
About Miku Oda
Miku Oda is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Physiology, Oncology and Epidemiology, having authored 18 papers that have together received 152 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Medical Imaging and Pathology Studies (4 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers), IgG4-Related and Inflammatory Diseases (2 papers), Pneumonia and Respiratory Infections (2 papers), Antifungal resistance and susceptibility (2 papers), Pleural and Pulmonary Diseases (2 papers) and Cardiac Structural Anomalies and Repair (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (83 citations), Infectious Diseases (44 citations), Otorhinolaryngology (8 citations), Rheumatology (27 citations) and Physiology (45 citations). Miku Oda has collaborated with scholars based in Japan, Israel and Canada. Frequent co-authors include Takeshi Saraya, Masachika Fujiwara, Haruyuki Ishii, Hajime Takizawa, Kojiro Honda, Masaki Tamura, Takuma Yokoyama, Manami Inoue, Hiroaki Shimoyamada and Mitsuru Sada. Their work appears in journals such as Modern Rheumatology, Respiratory Medicine, Lung, Medicine and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.